58 related articles for article (PubMed ID: 29464331)
1. Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma.
Eibenberger K; Heimann H; Gatchalian L; Kacperek A; Hussain R
Ophthalmology; 2023 Sep; 130(9):958-965. PubMed ID: 37169262
[TBL] [Abstract][Full Text] [Related]
2. Influence of Post-radiation Ocular Surface Disorder on Ocular Surgery: A Case Report and Review of the Literature.
Gjukaj D; Morina I; Valmaggia C; Ammann D; Todorova MG
Klin Monbl Augenheilkd; 2024 Apr; 241(4):421-425. PubMed ID: 38653304
[TBL] [Abstract][Full Text] [Related]
3. Iris melanoma: factors predictive of post-management secondary glaucoma in 271 cases at a Single Ocular Oncology Centre.
Shukla AG; Vaidya S; Yaghy A; Di Nicola M; Kaliki S; Fulco E; Myers JS; Shields JA; Shields CL
Eye (Lond); 2023 Apr; 37(5):938-946. PubMed ID: 35383310
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium brachytherapy for iris melanoma.
Zwolin Ska E; Główka L; Chicheł A; Rospond-Kubiak I
J Contemp Brachytherapy; 2023 Oct; 15(5):344-349. PubMed ID: 38026074
[TBL] [Abstract][Full Text] [Related]
5. Salvage skull base surgery after proton beam therapy for recurrent sinonasal malignancies: A retrospective study.
Okada S; Mukaigawa T; Goto S; Hiiragi Y; Sato F; Deguchi S; Ogawa H; Onoe T; Murayama S; Yasunaga Y; Hayashi N
Head Neck; 2024 Feb; ():. PubMed ID: 38406918
[TBL] [Abstract][Full Text] [Related]
6. Salvage hepatectomy for local recurrence after particle therapy using proton and carbon ion beams for liver cancer.
Tanaka M; Komatsu S; Kido M; Toyama H; Tominaga M; Uchida Y; Terashima K; Demizu Y; Okimoto T; Fukumoto T
Ann Gastroenterol Surg; 2021 Sep; 5(5):711-719. PubMed ID: 34585055
[TBL] [Abstract][Full Text] [Related]
7. Metastatic iris tumor.
Onda M; Makino S
QJM; 2023 Sep; 116(8):694-695. PubMed ID: 37086431
[No Abstract] [Full Text] [Related]
8. The Highlighted Role of GAPDH and Nitric-Oxide Synthase Regulator Activity in Proton Beam Irradiated Melanoma BLM Cells.
Zadeh-Esmaeel MM; Shahrokh S; Zamanian Azodi M; Ahmadi N
J Lasers Med Sci; 2019; 10(Suppl 1):S68-S72. PubMed ID: 32021677
[No Abstract] [Full Text] [Related]
9. Proton Beam Therapy Training, Experience, and Assessment: Ready for Prime Time.
Wallner PE; Jimenez RB; Davis BJ; Steinberg ML
Pract Radiat Oncol; 2023; 13(4):286-288. PubMed ID: 37391235
[No Abstract] [Full Text] [Related]
10. Young Adult Secondary Cancer After Proton Beam Therapy: A Case Study.
Yamamori A; Murayama S; Takahashi I; Akaihata M; Kakuda Y; Sugino T; Aramaki T; Onoe T; Takahashi Y; Ishida Y
Adv Radiat Oncol; 2024 Jan; 9(1):101307. PubMed ID: 38260212
[No Abstract] [Full Text] [Related]
11. [New treatment options for iridociliary tumors].
Mor JM; Koch KR; Kakkassery V; Cursiefen C; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):332-339. PubMed ID: 30515574
[TBL] [Abstract][Full Text] [Related]
12. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
13. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
14. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapeutic and surgical management of iris melanoma: A review.
Popovic M; Ahmed IIK; DiGiovanni J; Shields CL
Surv Ophthalmol; 2017; 62(3):302-311. PubMed ID: 28062196
[TBL] [Abstract][Full Text] [Related]
16. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.
Riechardt AI; Klein JP; Cordini D; Heufelder J; Rehak M; Seibel I; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1325-1332. PubMed ID: 29464331
[TBL] [Abstract][Full Text] [Related]
17. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
